| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 46.428.373 $ | 63,04 | 1.191.155 | |||||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 3.433.611 $ | 4,66 | 25.542 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 3.426.814 $ | 4,65 | 7.657 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 3.301.552 $ | 4,48 | 9.803 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 2.360.755 $ | 3,21 | 3.840 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 1.480.910 $ | 2,01 | 4.904 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 1.153.698 $ | 1,57 | 7.326 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 1.063.300 $ | 1,44 | 5.425 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 921.213 $ | 1,25 | 5.653 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 902.048 $ | 1,22 | 1.620 | |
| Royalty Pharma plc | Royalty Pharma plc, Class A | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 883.071 $ | 1,20 | 15.837 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 877.790 $ | 1,19 | 1.050 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 851.859 $ | 1,16 | 7.968 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 793.535 $ | 1,08 | 26.460 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 711.910 $ | 0,97 | 7.359 | |
| Viatris, Inc. | Viatris, Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 692.107 $ | 0,94 | 42.565 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 688.974 $ | 0,94 | 14.600 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 628.997 $ | 0,85 | 4.850 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 587.610 $ | 0,80 | 3.712 | |
| Jazz Pharmaceuticals plc | Jazz Pharmaceuticals plc | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 538.015 $ | 0,73 | 2.275 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | DK0060615755 | Long | Börsenkurs (Stufe 1) | 510.074 $ | 0,69 | 2.276 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 502.767 $ | 0,68 | 28.664 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 484.608 $ | 0,66 | 9.600 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 474.885 $ | 0,64 | 7.167 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 469.913 $ | 0,64 | 1.051 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 467.339 $ | 0,63 | 6.109 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 443.167 $ | 0,60 | 1.890 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 421.188 $ | 0,57 | 847 | |
| BioMarin Pharmaceutical, Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 407.332 $ | 0,55 | 7.110 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 404.237 $ | 0,55 | 4.213 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 403.418 $ | 0,55 | 5.178 | |
| Sanofi SA | Sanofi SA | EC | 80105N105 | Long | Börsenkurs (Stufe 1) | 395.082 $ | 0,54 | 9.047 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 360.119 $ | 0,49 | 1.029 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 349.488 $ | 0,47 | 4.553 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 340.034 $ | 0,46 | 1.181 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 333.752 $ | 0,45 | 1.080 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 324.219 $ | 0,44 | 6.424 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 301.203 $ | 0,41 | 2.271 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 298.605 $ | 0,41 | 2.705 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 290.381 $ | 0,39 | 4.364 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 285.820 $ | 0,39 | 38.008 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 273.499 $ | 0,37 | 5.321 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 260.017 $ | 0,35 | 6.163 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 250.516 $ | 0,34 | 7.523 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 245.644 $ | 0,33 | 3.017 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 235.061 $ | 0,32 | 2.361 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 226.447 $ | 0,31 | 2.231 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 226.129 $ | 0,31 | 3.062 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 223.096 $ | 0,30 | 2.526 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 213.518 $ | 0,29 | 2.905 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 209.830 $ | 0,28 | 6.002 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 199.439 $ | 0,27 | 3.550 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 194.532 $ | 0,26 | 3.123 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 186.009 $ | 0,25 | 3.773 | |
| Centessa Pharmaceuticals plc | Centessa Pharmaceuticals plc | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 175.858 $ | 0,24 | 4.423 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 174.406 $ | 0,24 | 10.431 | |
| Ligand Pharmaceuticals, Inc. | Ligand Pharmaceuticals, Inc. | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 170.723 $ | 0,23 | 736 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 168.240 $ | 0,23 | 3.074 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 166.580 $ | 0,23 | 2.028 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 166.556 $ | 0,23 | 4.624 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 160.837 $ | 0,22 | 3.409 | |
| Amneal Pharmaceuticals, Inc. | Amneal Pharmaceuticals, Inc. | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 153.193 $ | 0,21 | 11.632 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 151.527 $ | 0,21 | 2.266 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 146.941 $ | 0,20 | 11.444 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 143.207 $ | 0,19 | 4.252 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 137.650 $ | 0,19 | 3.872 | |
| ACADIA Pharmaceuticals, Inc. | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 136.523 $ | 0,19 | 6.303 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 136.147 $ | 0,18 | 2.938 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 135.479 $ | 0,18 | 3.966 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 124.047 $ | 0,17 | 3.767 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 123.358 $ | 0,17 | 5.863 | |
| 10X Genomics, Inc. | 10X Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 123.155 $ | 0,17 | 4.351 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 117.662 $ | 0,16 | 6.087 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 113.299 $ | 0,15 | 2.880 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 109.416 $ | 0,15 | 4.978 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 104.710 $ | 0,14 | 1.789 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 103.148 $ | 0,14 | 1.439 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 100.958 $ | 0,14 | 4.674 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 98.437 $ | 0,13 | 4.587 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 98.163 $ | 0,13 | 1.411 | |
| Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 97.902 $ | 0,13 | 2.120 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 95.660 $ | 0,13 | 3.246 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 93.631 $ | 0,13 | 2.636 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 93.436 $ | 0,13 | 1.573 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 92.814 $ | 0,13 | 6.606 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 92.138 $ | 0,13 | 2.925 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 89.140 $ | 0,12 | 3.685 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 86.896 $ | 0,12 | 2.196 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 86.234 $ | 0,12 | 5.692 | |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 85.490 $ | 0,12 | 3.571 | |
| Legend Biotech Corp. | Legend Biotech Corp. | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 84.794 $ | 0,12 | 3.122 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 82.781 $ | 0,11 | 2.255 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 82.605 $ | 0,11 | 9.271 | |
| Kiniksa Pharmaceuticals International plc | Kiniksa Pharmaceuticals International plc, Class A | EC | GB00BRXB0C07 | Long | Börsenkurs (Stufe 1) | 82.149 $ | 0,11 | 1.698 | |
| Aurinia Pharmaceuticals, Inc. | Aurinia Pharmaceuticals, Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 75.332 $ | 0,10 | 4.914 | |
| Ocular Therapeutix, Inc. | Ocular Therapeutix, Inc. | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 72.521 $ | 0,10 | 8.049 | |
| Novocure Ltd. | Novocure Ltd. | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 71.721 $ | 0,10 | 4.209 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 71.389 $ | 0,10 | 2.367 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 70.696 $ | 0,10 | 1.651 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 70.264 $ | 0,10 | 8.805 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 69.678 $ | 0,09 | 1.764 | |
| Zymeworks, Inc. | Zymeworks, Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 69.510 $ | 0,09 | 2.766 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 69.276 $ | 0,09 | 19.297 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 69.246 $ | 0,09 | 3.875 | |
| AbCellera Biologics, Inc. | AbCellera Biologics, Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 69.160 $ | 0,09 | 11.209 | |
| Harmony Biosciences Holdings, Inc. | Harmony Biosciences Holdings, Inc. | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 67.603 $ | 0,09 | 2.140 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 67.524 $ | 0,09 | 3.802 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 67.052 $ | 0,09 | 4.742 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 66.072 $ | 0,09 | 6.023 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 65.951 $ | 0,09 | 1.974 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 65.762 $ | 0,09 | 2.305 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 65.251 $ | 0,09 | 2.111 | |
| ANI Pharmaceuticals, Inc. | ANI Pharmaceuticals, Inc. | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 65.163 $ | 0,09 | 830 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 63.883 $ | 0,09 | 3.261 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 63.680 $ | 0,09 | 2.166 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 62.639 $ | 0,09 | 2.379 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 62.494 $ | 0,08 | 1.875 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 62.451 $ | 0,08 | 15.232 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 61.472 $ | 0,08 | 4.369 | |
| AtaiBeckley, Inc. | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 60.833 $ | 0,08 | 13.429 | |
| Taysha Gene Therapies, Inc. | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 59.451 $ | 0,08 | 10.128 | |
| Innoviva, Inc. | Innoviva, Inc. | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 58.691 $ | 0,08 | 2.740 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 58.247 $ | 0,08 | 4.059 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 56.950 $ | 0,08 | 1.023 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 56.767 $ | 0,08 | 13.080 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 55.853 $ | 0,08 | 537 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 55.543 $ | 0,08 | 2.818 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 55.427 $ | 0,08 | 5.810 | |
| GH Research plc | GH Research plc | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 55.033 $ | 0,07 | 2.294 | |
| Ardelyx, Inc. | Ardelyx, Inc. | EC | 039697107 | Long | Börsenkurs (Stufe 1) | 54.759 $ | 0,07 | 9.066 | |
| Fortrea Holdings, Inc. | Fortrea Holdings, Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 53.172 $ | 0,07 | 3.455 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 52.177 $ | 0,07 | 1.658 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 50.960 $ | 0,07 | 2.343 | |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 50.247 $ | 0,07 | 1.870 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 50.041 $ | 0,07 | 1.657 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | IL0011407140 | Long | Börsenkurs (Stufe 1) | 48.665 $ | 0,07 | 1.730 | |
| Harrow, Inc. | Harrow, Inc. | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 48.238 $ | 0,07 | 1.370 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 47.046 $ | 0,06 | 1.778 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 46.831 $ | 0,06 | 1.621 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 46.222 $ | 0,06 | 1.527 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 45.797 $ | 0,06 | 6.960 | |
| Compass Pathways plc | Compass Pathways plc | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 45.540 $ | 0,06 | 3.487 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 44.107 $ | 0,06 | 3.869 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 42.937 $ | 0,06 | 11.389 | |
| EyePoint, Inc. | EyePoint, Inc. | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 41.582 $ | 0,06 | 3.062 | |
| Alvotech SA | Alvotech SA | EC | LU2458332611 | Long | Börsenkurs (Stufe 1) | 41.026 $ | 0,06 | 12.210 | |
| Collegium Pharmaceutical, Inc. | Collegium Pharmaceutical, Inc. | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 39.391 $ | 0,05 | 1.172 | |
| Savara, Inc. | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 39.125 $ | 0,05 | 7.524 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 39.069 $ | 0,05 | 2.962 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 37.900 $ | 0,05 | 3.054 | |
| Xeris Biopharma Holdings, Inc. | Xeris Biopharma Holdings, Inc. | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 37.785 $ | 0,05 | 6.134 | |
| Absci Corp. | Absci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 37.537 $ | 0,05 | 5.561 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 36.487 $ | 0,05 | 1.983 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 35.921 $ | 0,05 | 2.185 | |
| Grifols SA | Grifols SA | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 35.404 $ | 0,05 | 4.510 | |
| Pacira BioSciences, Inc. | Pacira BioSciences, Inc. | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 34.714 $ | 0,05 | 1.495 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 33.160 $ | 0,05 | 3.656 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 32.842 $ | 0,04 | 2.251 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 32.824 $ | 0,04 | 3.218 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 32.502 $ | 0,04 | 9.849 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 32.422 $ | 0,04 | 7.110 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 32.207 $ | 0,04 | 2.711 | |
| MeiraGTx Holdings plc | MeiraGTx Holdings plc | EC | KYG596651029 | Long | Börsenkurs (Stufe 1) | 31.684 $ | 0,04 | 2.975 | |
| Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 31.611 $ | 0,04 | 1.677 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 31.358 $ | 0,04 | 3.711 | |
| Eton Pharmaceuticals, Inc. | Eton Pharmaceuticals, Inc. | EC | 29772L108 | Long | Börsenkurs (Stufe 1) | 30.206 $ | 0,04 | 992 | |
| Theravance Biopharma, Inc. | Theravance Biopharma, Inc. | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 30.113 $ | 0,04 | 1.875 | |
| Mesoblast Ltd. | Mesoblast Ltd. | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 29.784 $ | 0,04 | 1.934 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 29.503 $ | 0,04 | 23.602 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 28.992 $ | 0,04 | 5.349 | |
| Omeros Corp. | Omeros Corp. | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 28.947 $ | 0,04 | 2.622 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 27.926 $ | 0,04 | 2.912 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 27.733 $ | 0,04 | 1.604 | |
| Esperion Therapeutics, Inc. | Esperion Therapeutics, Inc. | EC | 29664W105 | Long | Börsenkurs (Stufe 1) | 27.660 $ | 0,04 | 8.837 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 26.531 $ | 0,04 | 3.053 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 25.968 $ | 0,04 | 5.410 | |
| CorMedix, Inc. | CorMedix, Inc. | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 24.569 $ | 0,03 | 2.911 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 24.142 $ | 0,03 | 2.083 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 23.689 $ | 0,03 | 6.673 | |
| Phibro Animal Health Corp. | Phibro Animal Health Corp., Class A | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 23.493 $ | 0,03 | 763 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 23.188 $ | 0,03 | 1.100 | |
| Vor BioPharma, Inc. | Vor BioPharma, Inc. | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 22.994 $ | 0,03 | 1.536 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 22.554 $ | 0,03 | 6.265 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 22.468 $ | 0,03 | 2.707 | |
| Zai Lab Ltd. | Zai Lab Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 22.449 $ | 0,03 | 1.269 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 22.060 $ | 0,03 | 2.105 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 21.597 $ | 0,03 | 693 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc., Class A | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 21.520 $ | 0,03 | 6.028 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 21.220 $ | 0,03 | 2.363 | |
| Solid Biosciences, Inc. | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 21.139 $ | 0,03 | 2.880 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 20.489 $ | 0,03 | 672 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 20.288 $ | 0,03 | 4.459 | |
| Prothena Corp. plc | Prothena Corp. plc | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 20.248 $ | 0,03 | 1.989 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 18.680 $ | 0,03 | 1.885 | |
| Aquestive Therapeutics, Inc. | Aquestive Therapeutics, Inc. | EC | 03843E104 | Long | Börsenkurs (Stufe 1) | 18.134 $ | 0,02 | 4.511 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 18.028 $ | 0,02 | 8.308 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 17.994 $ | 0,02 | 2.112 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 17.547 $ | 0,02 | 2.349 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 17.051 $ | 0,02 | 2.464 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 16.695 $ | 0,02 | 1.997 | |
| Kamada Ltd. | Kamada Ltd. | EC | IL0010941198 | Long | Börsenkurs (Stufe 1) | 16.667 $ | 0,02 | 2.134 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 16.633 $ | 0,02 | 11.163 | |
| First Tracks Biotherapeutics, Inc. | First Tracks Biotherapeutics, Inc. | EC | 337185102 | Long | Börsenkurs (Stufe 1) | 16.327 $ | 0,02 | 1.023 | |
| Neurogene, Inc. | Neurogene, Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 16.182 $ | 0,02 | 571 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 15.771 $ | 0,02 | 3.609 | |
| Evolus, Inc. | Evolus, Inc. | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 15.724 $ | 0,02 | 2.397 | |
| Lakefront Biotherapeutics NV | Lakefront Biotherapeutics NV | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 15.536 $ | 0,02 | 548 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 15.163 $ | 0,02 | 1.124 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 14.369 $ | 0,02 | 5.322 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 14.125 $ | 0,02 | 4.631 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 14.108 $ | 0,02 | 1.072 | |
| Vanda Pharmaceuticals, Inc. | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 14.100 $ | 0,02 | 2.186 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 13.969 $ | 0,02 | 4.014 | |
| Autolus Therapeutics plc | Autolus Therapeutics plc | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 13.864 $ | 0,02 | 7.414 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 13.863 $ | 0,02 | 2.697 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 13.773 $ | 0,02 | 2.387 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 13.639 $ | 0,02 | 787 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 13.492 $ | 0,02 | 2.889 | |
| Puma Biotechnology, Inc. | Puma Biotechnology, Inc. | EC | 74587V107 | Long | Börsenkurs (Stufe 1) | 13.472 $ | 0,02 | 1.879 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 13.445 $ | 0,02 | 3.557 | |
| REGENXBIO, Inc. | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 13.130 $ | 0,02 | 1.873 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 12.656 $ | 0,02 | 1.125 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 12.494 $ | 0,02 | 3.611 | |
| SIGA Technologies, Inc. | SIGA Technologies, Inc. | EC | 826917106 | Long | Börsenkurs (Stufe 1) | 12.383 $ | 0,02 | 2.646 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 12.320 $ | 0,02 | 4.013 | |
| Silence Therapeutics plc | Silence Therapeutics plc | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 11.978 $ | 0,02 | 1.736 | |
| Invivyd, Inc. | Invivyd, Inc. | EC | 00534A102 | Long | Börsenkurs (Stufe 1) | 11.678 $ | 0,02 | 10.244 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 11.426 $ | 0,02 | 6.176 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 10.697 $ | 0,01 | 1.981 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 10.381 $ | 0,01 | 3.426 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 10.011 $ | 0,01 | 1.416 | |
| AC Immune SA | AC Immune SA | EC | CH0329023102 | Long | Börsenkurs (Stufe 1) | 9.898 $ | 0,01 | 3.721 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 9.277 $ | 0,01 | 7.136 | |
| Foghorn Therapeutics, Inc. | Foghorn Therapeutics, Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 9.266 $ | 0,01 | 2.165 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 9.255 $ | 0,01 | 3.341 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 9.009 $ | 0,01 | 1.158 | |
| Coherus Oncology, Inc. | Coherus Oncology, Inc. | EC | 19249H103 | Long | Börsenkurs (Stufe 1) | 8.785 $ | 0,01 | 5.525 | |
| Quantum-Si, Inc. | Quantum-Si, Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 8.604 $ | 0,01 | 7.230 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 8.433 $ | 0,01 | 2.179 | |
| Sagimet Biosciences, Inc. | Sagimet Biosciences, Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 8.362 $ | 0,01 | 1.147 | |
| Arcturus Therapeutics Holdings, Inc. | Arcturus Therapeutics Holdings, Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 8.332 $ | 0,01 | 1.052 | |
| Orchestra BioMed Holdings, Inc. | Orchestra BioMed Holdings, Inc. | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 8.168 $ | 0,01 | 2.089 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 8.151 $ | 0,01 | 3.454 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 8.025 $ | 0,01 | 1.711 | |
| NovaBridge Biosciences | NovaBridge Biosciences | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 7.638 $ | 0,01 | 4.151 | |
| Lifecore Biomedical, Inc. | Lifecore Biomedical, Inc. | EC | 514766104 | Long | Börsenkurs (Stufe 1) | 6.963 $ | 0,01 | 1.387 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 6.962 $ | 0,01 | 8.012 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | KYG831161065 | Long | Börsenkurs (Stufe 1) | 6.035 $ | 0,01 | 2.743 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 4.673 $ | 0,01 | 2.105 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 4.145 $ | 0,01 | 2.303 | |
| PepGen, Inc. | PepGen, Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 3.812 $ | 0,01 | 2.541 | |
| Rani Therapeutics Holdings, Inc. | Rani Therapeutics Holdings, Inc., Class A | EC | 753018100 | Long | Börsenkurs (Stufe 1) | 3.430 $ | 0,00 | 3.608 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 3.304 $ | 0,00 | 804 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 1.975 $ | 0,00 | 8.555 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 0 $ | 0,00 | 1.662 | |
| 46.428.373 $ | 63,04 | 1.191.155 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.